Search for: "Clark v. AT&T Corporation" Results 241 - 260 of 324
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2011, 8:28 am by tjsllibrary
” Apparently the hackers had even tried to sell the information back to Sony, but they didn’t receive a reply from the Japanese electronics company” (Mogg). [read post]
23 Apr 2012, 3:04 am by INFORRM
He did not work for NME and was never discarded by the IPC as a possible editor for the magazine.” Jeremy Clarke-Williams, Russell Jones Walker, acted for the claimant. [read post]
27 Dec 2013, 1:19 pm by Monique Altheim
Big Data   The E-Books Are Reading You #EUdataP http://www.nytimes.com/2013/12/25/technology/as-new-services-track-habits-the-e-books-are-reading-you.html … Retailers, Supermarkets, Medical Markets Dive In To Extract Information From And About Consumers http://ow.ly/rYTdJ      California Privacy   California’s New Do-Not-Track Law Goes Into Effect January 1, 2014, Remember To Check Your Privacy Policy For … http://ow.ly/2Clqu3    CAN-SPAM… [read post]
9 Jun 2021, 1:39 pm by Giles Peaker
The right to move an occupier from one room to another is inconsistent with exclusive possession (see Westminster City Council v Clarke (1992) 2 AC 288). [read post]
14 Feb 2014, 12:00 pm by Mary Pat Dwyer
Clark 13-555Issue: Whether a federal court has authority in extraordinary circumstances to bar a state from reprosecuting a defendant when state officials violate a federal habeas order and engage in continuing misconduct that substantially prejudices the defendant’s ability to secure a fair retrial. [read post]
26 Jun 2016, 4:05 pm by INFORRM
” The Zelo Street blog has a piece on Louise Mensch and the referendum result: “Don’t Menshn Brexit, Stupid” Last week in the Courts The trial in Economou v De Freitas continued on 20 and 22 June 2016 before Warby J. [read post]
16 Mar 2011, 3:55 am
 The latest offering from the jiplp weblog, which offers free extracts from the Journal of Intellectual Property Law and Practice (JIPLP), is this Current Intelligence note by editorial board member Charles Macedo on patent eligibility in the US and the protection of abstract ideas, arising from Research Corporation Technologies Inc v Microsoft Corp. [read post]
20 Jun 2018, 5:00 pm by John Elwood
In Nutraceutical Corporation v. [read post]
13 Oct 2008, 12:12 pm
Patent landscape analytics may prove you wrong (IP Asset Maximizer Blog) Why sinking markets could mean real opportunities for patent acquirers and licensees (IAM)   Global - Copyright Copyright still viable, at least for top authors (IP finance) Understanding the backlash cost in copying someone else's work (Techdirt)   Africa Designers from all OAPI (Organisation Africaine de la Propriete Intellectuelle) countries to benefit from fee reductions (Afro-IP) (WIPO) WIPO and… [read post]
24 May 2023, 6:37 am by Paula Junghans
DA Office: “[T]he People further refer defendant to certain facts, among others, set forth in the Statement of Facts relating to … disguising reimbursement payments by doubling them and falsely characterizing them as income for tax reasons Court filing in response to defendant’s request for bill of particulars. [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]